SCHEMBL7615005

SCHEMBL7615005

N[C@@H](Cc1ccc(-c2cnccn2)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 12/20 0.55
SLC7A5 Q01650 3/20 0.51
HSD17B10 Q99714 2/20 0.50
PTGS1 P23219 2/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
XIAP P98170 1/20 0.50
PIM1 P11309 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
GRB2 P62993 1/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44
EGFR P00533 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
ALOX15 P16050 1/20 0.44
HTR2A P28223 1/20 0.44
PTGS2 P35354 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615000 1.00 TPH1 (0.55) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL6163441 0.84 TPH1 (0.45) TPH1PIM1PIM2PTGS2
Hydrochloric Acid SCHEMBL6163436 0.83 TPH1 (0.44) TPH1PIM1PIM2PTGS2
SCHEMBL7610102 0.81 TPH1 (0.61) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL7610098 0.81 TPH1 (0.61) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL30722996 0.81 TPH1 (0.61) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL11826134 0.79 MMP12 (0.48) PIM1PIM2MME
SCHEMBL29499922 0.79 TPH1 (0.51) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL25868518 0.79 TPH1 (0.51) TPH1SLC7A5HSD17B10PTGS1ALPI
SCHEMBL31398347 0.79 SLC7A5 (0.61) TPH1SLC7A5HSD17B10PTGS1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448408-B1 CHEMICAL INTERMEDIATES IN PREPARATION OF N-MERCAPTOACYL DERIVATIVE OF PHENYLALANINE WITH PHARMALOGICAL ACTIVITY ZAMBON GROUP S.P.A. (IT) 2002-09-10 US disclosed
US-20020028946-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-PHENYLALANINES ZAMBON GROUP S.P.A. (IT) 2002-03-07 US disclosed
EP-0948492-B1 PROCESS FOR THE PREPARATION OF HETEROARYL-PHENYLALANINES ZAMBON SPA (IT) 2001-07-11 EP disclosed
EP-0948492-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-PHENYLALANINES ZAMBON GROUP S.p.A. (IT) 1999-10-13 EP disclosed
WO-1998028284-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-PHENYLALANINES ZAMBON GROUP S.P.A. (IT) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028946-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-PHENYLALANINES PAH, TYR, CYP2S1 TPH1 61/4885SLC7A5 51/4885HSD17B10 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.